Delivery Order SPE2DB24D3014-SPE2DB24FKRWQ

Award Date 8/2/24
Potential Completion Date 8/5/24
Potential Value $34K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a $2,203.97 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the supply of 4565698000 - Lidocaine 5% Patch 30s, a pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that Amerisourcebergen holds with DLA Troop Support Medical to provide a comprehensive range of medical commodities in support of military...
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $7,459.20 firm fixed price delivery order to provide 4,563,744,113 units of Lidocaine 5% Patch 30S. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $15,955.13 contract is for the delivery of 4,567,999,086 units of Lidocaine 5% Patches. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides global pharmaceutical support services to military healthcare programs through...
The U.S. Defense Logistics Agency (DLA) awarded a $22,166.06 firm fixed price delivery order contract to AmerisourceBergen Drug Corp for the supply of 4565922795 - Lidocaine 5% Patch 30s. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 with DLA Troop Support Medical for providing a comprehensive range of pharmaceutical and medical supplies to support military treatment programs and facilities worldwide. There is no set-aside designation for this...
This is a $1,739.04 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,526,500 units of a 5% lidocaine patch product. The order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical for delivering a comprehensive range of medical commodities to support military treatment programs and...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,399.62 to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical company AmerisourceBergen Corporation. The contract is for the delivery of Lidocaine 5% Patch 30s, a pharmaceutical product, with a performance period through March 14, 2024. This delivery order is issued under a larger, single-award indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp,...
The Defense Logistics Agency (DLA) awarded a $14,121.12 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,057,471 units of Lidocaine 5% patch. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which covers a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs...
The Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, to provide 4564714526 - Lidocaine 5% Patch 30S. The $2,061.23 firm fixed-price contract has a completion date of May 28, 2024. This order is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of...
This is a $26,859.40 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the supply of 4,565,927,211 units of Lidocaine 5% Patches, a pharmaceutical product, with a completion date of September 25, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $10,403.97 contract is for the delivery of 4,565,286,307 units of Lidocaine 5% Patch 30s, a pharmaceutical product used for pain management. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 through December 2025, which enables the DLA to efficiently procure a...
  • SPE2DB24D3014
    Indefinite Delivery Contract
  • SPE2DB24D3014-SPE2DB24FKRWQ
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a $34,144.17 Firm Fixed Price delivery order to AmerisourceBergen Drug Corp for the supply of 4,565,331,242 units of Lidocaine 5% Patch 30s. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation and is expected to be completed by August 5, 2024.

Generated 11/1/24, 10:18 AM